NCT02238314View on ClinicalTrials.gov

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

August 31, 2001

Conditions
HIV Infections
Interventions
DRUG

Tipranavir low dose

DRUG

Tipranavir high dose

DRUG

Ritonavir

DRUG

Nucleoside Reverse Transcriptase Inhibitor (NRTI)

DRUG

Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY